Z

Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077

Watchlist Manager
Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
Watchlist
Price: 17.08 CNY 1.73% Market Closed
Market Cap: ¥5.2B

P/S

1.4
Current
14%
Cheaper
vs 3-y average of 1.6

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
1.4
=
Market Cap
¥5.1B
/
Revenue
¥3.7B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
1.4
=
Market Cap
¥5.1B
/
Revenue
¥3.7B

Valuation Scenarios

Zhejiang Huakang Pharmaceutical Co Ltd is trading below its 3-year average

If P/S returns to its 3-Year Average (1.6), the stock would be worth ¥19.77 (16% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+95%
Average Upside
37%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 1.4 ¥17.08
0%
3-Year Average 1.6 ¥19.77
+16%
5-Year Average 1.7 ¥20.38
+19%
Industry Average 1.7 ¥20.25
+19%
Country Average 2.8 ¥33.38
+95%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
¥5.1B
/
Oct 2025
¥3.7B
=
1.4
Current
¥5.1B
/
Dec 2025
¥4.2B
=
1.2
Forward
¥5.1B
/
Dec 2026
¥5.5B
=
0.9
Forward
¥5.1B
/
Dec 2027
¥6.6B
=
0.8
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close

Market Distribution

Lower than 71% of companies in China
Percentile
29th
Based on 7 736 companies
29th percentile
1.4
Low
0 — 1.5
Typical Range
1.5 — 5.4
High
5.4 —
Distribution Statistics
China
Min 0
30th Percentile 1.5
Median 2.8
70th Percentile 5.4
Max 5 034 353.9

Zhejiang Huakang Pharmaceutical Co Ltd
Glance View

Market Cap
5.2B CNY
Industry
Food Products

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of functional sugar alcohols and starch sugar products. The company is headquartered in Quzhou, Zhejiang and currently employs 1,303 full-time employees. The company went IPO on 2021-02-09. The firm's main products are xylitol, sorbitol, maltitol and grape syrup. Its products are mainly used in food, beverage, daily chemical and other fields. The firm conducts its businesses within the China market and to overseas markets such as Europe, America and Asia.

Intrinsic Value
16.22 CNY
Overvaluation 5%
Intrinsic Value
Price ¥17.08
Z
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett